Drug Search Results
More Filters [+]

Rostaporfin

Alternative Names: rostaporfin
Latest Update: 2005-12-01
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Miravant
Company Location: SANTA BARBARA CA 93117
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Rostaporfin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Macular Degeneration|Choroidal Neovascularization

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2005-001856-19

P3

Terminated

Macular Degeneration|Choroidal Neovascularization

2008-04-25

MRVT-920101-OPH005

P3

Unknown status

Macular Degeneration|Choroidal Neovascularization

None

Recent News Events

Date

Type

Title